Results 41 to 50 of about 206,114 (317)
Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. [PDF]
, 2013 In resource-constrained settings, tuberculosis (TB) is a common opportunistic infection and cause of death in HIV-infected persons. TB may be present at the start of antiretroviral therapy (ART), but it is often under-diagnosed. We describe approaches to
Samuel Ajayi +110 more
core +1 more source
BMC Infectious Diseases, 2023 Objective This study investigated the diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra (Ultra) for detecting smear-negative pulmonary tuberculosis (TB).
Lan Yao, Shanhao Chen, Wei Sha, Ye Gu
doaj +1 more source
THE DIAGNOSIS OF PULMONARY TUBERCULOSIS [PDF]
BMJ, 1900 This may be a matter of considerable ease, or one of extreme difficulty, depending on the stage of the disease and the nature of the pathologic conditions. Let us first consider its diagnosis at an early stage. Tuberculosis is an infection, and as is the rule with infections, it occasions a rise of temperature even at its incipiency. Except very rarely,
openaire +1 more source
Diagnostics for pulmonary tuberculosis [PDF]
Postgraduate Medical Journal, 2016 AbstractTuberculosis (TB) remains a leading cause of human suffering and mortality despite decades of effective treatment being available. Accurate and timely diagnosis remains an unmet goal. The HIV epidemic has also led to new challenges in the diagnosis of TB.
Patrick Cudahy, Sheela V Shenoi
openaire +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
The regulation and potential role of interleukin-32 in tuberculous pleural effusion
Frontiers in ImmunologyThe possible protective effect of interleukin-32 (IL-32) in Mycobacterium tuberculosis (Mtb) infection has been indicated. However, few studies have been focused on IL-32 in tuberculosis patients.
Xuan Wang +8 more
doaj +1 more source
International Journal of Infectious Diseases, 2021 Objective: To evaluate he diagnostic performance of the Xpert Mycobacterium tuberculosis/Rifampin (MTB/RIF) assay in bronchoalveolar lavage fluid (BALF).
Juan Yang +9 more
doaj +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. [PDF]
, 2009 BACKGROUND: The Stop TB Partnership target for tuberculosis is to have reduced the prevalence of tuberculosis by 50% comparing 2015 to 1990. This target is challenging as few prevalence surveys have been conducted, especially in high burden tuberculosis ...
Beyers, Nulda +26 more
core +1 more source